Major trauma

Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss

Retrieved on: 
Monday, December 4, 2023
Health, Telemedicine, Virtual Medicine, Fitness & Nutrition, General Health, Vitamins, Supplements, Pharmaceutical, Topiramate, Metformin, Hims & Hers Health, Sleep, Obesity, Depression, Research, NYSE, FACP, Naltrexone, Major trauma, Medication, Psychology, Gambling, Overweight, Patient, Multimedia, FAAP, Movement, FOMA, Motivation, Weight gain, Digital, Weight loss, MD, CDC, SVP, Heart Health Park, Vitamin B12, Birth control, Nursing, Dietary supplement, Behavior, Hers, Bupropion

View the full release here: https://www.businesswire.com/news/home/20231204073836/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20231204073836/en/
    Weight Loss by Hims & Hers (Graphic: Business Wire)
    The science-backed Weight Loss by Hims & Hers program is developed with the expert insight of Dr. Primack and a team of clinical experts in obesity medicine, psychology and nutrition.
  • The program offers a well-rounded and more affordable approach to reducing weight by addressing the underlying factors that affect people’s weight – Nutrition, Behavior, Movement and Medical Treatment.
  • Weight Loss by Hims & Hers aims to address these issues by taking on the physical and psychological factors that contribute to weight gain and loss.
  • For more information on Hims & Hers’ weight loss program, please visit https://www.forhers.com/weight-loss and https://www.hims.com/c/wm/introduction .

U.S. Army awards BAE Systems $797 million contract to begin full rate production of Armored Multi-Purpose Vehicle

Retrieved on: 
Friday, September 1, 2023
Armored Multi-Purpose Vehicle, LSE, Maintenance, BA, Medical evacuation, LRIP, Army, Major trauma, BAE Systems Platforms & Services, Brigade combat team, BAE Systems, Woman, Armour, Mortar carrier, 30th Armored Brigade Combat Team, Mission command, United States Department of the Army, Platform, Air Warrior (U.S. Army), ABCT, AMPV, General-purpose, Food industry, Gasoline

YORK, Pa., Sept. 1, 2023 /PRNewswire/ -- BAE Systems (LSE: BA) received a $797 million contract to continue production of the Armored Multi-Purpose Vehicle (AMPV) for the U.S. Army, with additional options for a potential total contract amount of $1.6 billion.

Key Points: 
  • YORK, Pa., Sept. 1, 2023 /PRNewswire/ -- BAE Systems (LSE: BA) received a $797 million contract to continue production of the Armored Multi-Purpose Vehicle (AMPV) for the U.S. Army, with additional options for a potential total contract amount of $1.6 billion.
  • The multi-mission AMPV family of vehicles provides critical survivability, mobility, and interoperability upgrades to the Armored Brigade Combat Team (ABCT).
  • "Entering full-rate production is a momentous milestone in the lifecycle of a production program for both the U.S. Army and BAE Systems," said Jeremy Tondreault, president of the Platforms & Services sector at BAE Systems.
  • The Army first awarded BAE Systems the AMPV contract in 2014 and signed a low-rate initial production (LRIP) contract in 2018.

One Call Celebrates the Strength and Determination of Injured Workers With the Launch of Injured to Empowered

Retrieved on: 
Wednesday, July 19, 2023
Learning, Heart, National Safety Month, Elbow, Life, Paraplegia, Safe, Attitude, OSHA, Amputation, Cooking, Major trauma, Love, Tetraplegia, Injury, Safety, Management, Insurance, Nursing

JACKSONVILLE, Fla., July 19, 2023 /PRNewswire/ -- One Call, the nation's leading care coordinator of ancillary services for the workers' compensation industry, today announced the launch of its Injured to Empowered™ program, an ongoing celebration of injured workers who have risen above their injuries.

Key Points: 
  • One Call, along with its partners, plays a vital role in these journeys by getting injured workers the care they need when they need it.
  • While we can't completely prevent these injuries from occurring, we can help injured workers strive for a quality life post-injury."
  • "Injured to Empowered reinforces our purpose-driven approach to workers' compensation," said One Call CEO Jay Krueger.
  • Watch Billy P's full story on the Injured to Empowered webpage, onecallcm.com/empowered , and visit often for additional success stories.

BAE Systems to expand key production lines at its York site

Retrieved on: 
Friday, March 31, 2023
Other Manufacturing, Other Defense, Contracts, Military, Automotive Manufacturing, Manufacturing, Machinery, Government Technology, Machine Tools, Metalworking & Metallurgy, Defense, Bradley Fighting Vehicle, Medical evacuation, Major trauma, Amphibious Combat Vehicle, M88A2, Brigade combat team, Unitary state, Armored Multi-Purpose Vehicle, Multimedia, Armour, Government, Jack Hawkins (U.S. Marine Corps officer), Investment, 30th Armored Brigade Combat Team, ACV, BAE Systems, Fernald Feed Materials Production Center, BAE, Credit, M109A7, AMPV, General-purpose, Gasoline, Dredging

BAE Systems is expanding the Armored Multi-Purpose Vehicle (AMPV) and Amphibious Combat Vehicle (ACV) production lines at its York, Pennsylvania manufacturing site.

Key Points: 
  • BAE Systems is expanding the Armored Multi-Purpose Vehicle (AMPV) and Amphibious Combat Vehicle (ACV) production lines at its York, Pennsylvania manufacturing site.
  • The expansion is part of a broader investment in BAE Systems’ combat vehicle facilities that ensures its manufacturing sites have the capacity necessary to deliver capability to the U.S. Government with increased efficiency and innovation.
  • View the full release here: https://www.businesswire.com/news/home/20230331005303/en/
    The Armored Multi-Purpose Vehicle is manufactured in York, Penn.
  • “These changes will continue to leverage York’s infrastructure and deep experience in manufacturing combat vehicles, while increasing capacity and efficiency across other sites,” said Andy Corea, BAE Systems’ vice president, general manager for Combat Mission Systems.

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

Retrieved on: 
Monday, July 18, 2022
Medical Supplies, Biotechnology, Practice Management, FDA, Other Health, Health, General Health, Pharmaceutical, Medical Devices, Hospitals, Clinical Trials, Kidney, Skin, Agitation, Hospital, Lactation, Thyroid, Nervous, Heart, Iodixanol, Multimedia, Major trauma, Diagnosis, U.S. FDA, Blood, Sensation, Adult, CEO, Investment, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Cardiac arrest, Food, Anxiety, Brain, Medication, Incidence, Life, Breast milk, Taste, Vomiting, Headache, Google Images, Death, Geriatrics, Patient, Hypersensitivity, Nervous system, LLC, Dizziness, Smell, USP, COVID-19, Shock, Pain, Risk, CT, Nausea, Migraine, Syncope, The New York Times, Diarrhea, Radiology, Pediatrics, Fresenius (company), GE Healthcare, Iodine, Insomnia, Pharmaceutical marketing, FDA, Pharmaceutical industry, Medical imaging, Salt, Dietary supplement, Foodservice, Cancer

View the full release here: https://www.businesswire.com/news/home/20220718005543/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20220718005543/en/
    Fresenius Kabi Iodixanol Injection, USP is the first FDA-approved generic that is fully substitutable for Visipaque (Photo: Business Wire)
    Iodixanol Injection, USP is the first U.S. FDA-approved generic iso-osmolar, dimeric iodinated contrast media agent, which is used during diagnostic x-ray-based imaging such as computed tomography (CT) scans.
  • Iodixanol and other contrast media agents are in shortage across the U.S. due to COVID-19 related supply-chain disruptions.
  • Fresenius Kabi is pleased to help expand access to affordable, high-quality contrast media agents for the radiology community, said John Ducker, president and CEO of Fresenius Kabi USA.
  • The approval and U.S. availability of Fresenius Kabi Iodixanol Injection, USP is expected to provide immediate relief to the current shortage.

Las Vegas-Based COVID Testing Company OnSiteAble selected as Preferred Vendor of the U.S. Ski and Snowboard Team

Retrieved on: 
Thursday, January 20, 2022
Medical Supplies, Health, Skiing, Snowboarding, Sports, Medical Devices, Infectious Diseases, Other Health, Universe, Patient, Toyota, Vaccine, Secretary of State of Nevada, RT, U.S. International, Thermo Fisher Scientific, COVID-19, CLIA, Safety, ALL, ZOOM, Caesars Entertainment, Athlete, Sport, Government, Solution, COVID-19 testing, Instagram, Golden Entertainment, Insurance, Major trauma, Pro am, Facebook, PFL, Heavyweight, PBC, Education, Hewlett-Packard, Multimedia, PBR, UFC, Onsite sewage facility, Quarantine, Tennis, FDA, Organization, Lou Ruvo Center for Brain Health, COVID, Sports equipment, Pharmaceutical industry, Showtime, Bellator

OnSiteAble , a division of Las Vegas-based medical provider ProAm Sports Medicine (formerly Athlete Advantage Medical), has expanded their clientele and is now a preferred vendor of the U.S.

Key Points: 
  • OnSiteAble , a division of Las Vegas-based medical provider ProAm Sports Medicine (formerly Athlete Advantage Medical), has expanded their clientele and is now a preferred vendor of the U.S.
  • OnSiteAble provides safety and medical solutions for companies and individuals to safely enter work, school and events while abiding by government and employer mandates.
  • OnSiteAble is CLIA certified and contracted with high complexity labs and medical resources across the U.S. to provide both onsite and pre-travel, at-home COVID-19 testing solutions.
  • OnSiteAble medical personnel perform all testing under the proper licensing, insurance, and medical direction and managed by a proprietary technology platform.

LivaNova to Present Scientific Data on VNS Therapy for Drug-Resistant Epilepsy at American Epilepsy Society 2021 Annual Meeting

Retrieved on: 
Thursday, December 2, 2021
Research, Mental Health, Medical Devices, Clinical Trials, Other Health, Biotechnology, Alternative Medicine, General Health, Health, Science, People, Gaia, Comparison, Vagus nerve, Data mining, News, Pediatric neurosurgery, LGS, Risk, Postdoctoral researcher, Head, Conference, Annual report, Company, DBS, LivaNova, Vagus nerve stimulation, AES, Partnership, Seizure, LIVN, Anticonvulsant, Goal, Lennox–Gastaut syndrome, Annual general meeting, Hope, PLC, VNS, Research, Neurosurgery, American Epilepsy Society, RNS, DRE, FDA, Major trauma, Poster, Titration, Division, Catherine Disher, Doctor of Philosophy, Epilepsy, NASDAQ, Pharmaceutical industry, Medicine

The Company will present seven scientific posters aimed at engaging clinical collaborators and deepening understanding of the LivaNova VNS Therapy System for the treatment of drug-resistant epilepsy.

Key Points: 
  • The Company will present seven scientific posters aimed at engaging clinical collaborators and deepening understanding of the LivaNova VNS Therapy System for the treatment of drug-resistant epilepsy.
  • LivaNova pioneered the VNS Therapy System, which sends mild pulses to the vagus nerve via an implantable device.
  • The seven scientific poster presentations feature the work of LivaNova employees and/or independent investigators using the Companys VNS Therapy System in their research.
  • These statements include, but are not limited to, statements regarding participation in upcoming events and VNS Therapy for drug-resistant epilepsy.

Las Vegas Medical Provider ProAm Sports Medicine Launches New Division, OnSiteAble, Dedicated to Large-Scale Onsite COVID-19 Testing and Vaccine Services

Retrieved on: 
Tuesday, November 30, 2021
Professional Services, Health, Sports, Infectious Diseases, Human Resources, General Health, General Sports, Universe, Patient, Government, Sport, Insurance, CEO, Safety, Pro am, PBR, Partnership, Athlete, PFL, Education, Solution, Tennis, Vaccine, COVID-19, ALL, Hewlett-Packard, PBC, UFC, Golden Entertainment, Secretary of State of Nevada, COVID-19 testing, Quarantine, RT, Onsite health, Organization, COVID, Instagram, FDA, Major trauma, ZOOM, Thermo Fisher Scientific, Lou Ruvo Center for Brain Health, Multimedia, CLIA, Heavyweight, Facebook, Pharmaceutical industry

ProAm Sports Medicine (formerly Athlete Advantage Medical), a Las Vegas-based medical provider, announces the launch of a new company division, OnSiteAble , in partnership with AMR/MedicWest Ambulance.

Key Points: 
  • ProAm Sports Medicine (formerly Athlete Advantage Medical), a Las Vegas-based medical provider, announces the launch of a new company division, OnSiteAble , in partnership with AMR/MedicWest Ambulance.
  • View the full release here: https://www.businesswire.com/news/home/20211130005114/en/
    ProAm Sports Medicine (formerly Athlete Advantage Medical), a Las Vegas-based medical provider, announces the launch of a new company division, OnSiteAble, in partnership with AMR/MedicWest Ambulance.
  • OnSiteAble was established to meet the growing demand for enterprise-level COVID-19 testing services and vaccine verification nationwide for sports and entertainment events, corporate workplaces, education settings, tradeshows and conventions.
  • OnSiteAble medical personnel perform all testing under the proper licensing, insurance, and medical direction and managed by a proprietary technology platform.

Capricor Announces Joint Publication with the US Army Institute of Surgical Research for Cardiosphere-Derived Exosomes as a Potential Therapeutic for Shock

Retrieved on: 
Wednesday, August 4, 2021
Branches of biology, Medical emergencies, Acute pain, Traumatology, Vesicles, Cells, Extracellular vesicle, Vesicle, Major trauma, Coagulopathy, Injury, Shock

LOS ANGELES, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Capricor Therapeutics (“Capricor” or “the Company”) (NASDAQ: CAPR), a biotechnology company focused on developing transformative cell and exosome-based therapeutics for treating and preventing a broad spectrum of diseases, announced today the publication, of a manuscript, which shows that cardiosphere-derived exosomes (CDC-EVs) can attenuate kidney damage and promote new blood vessel formation in a preclinical model of acute trauma, both of which are important factors in post-shock recovery. The publication titled, “Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic” was published in the international peer-reviewed journal, The Journal of Trauma and Acute Care Surgery in collaboration with researchers at the United States Army Institute of Surgical Research (USAISR).

Key Points: 
  • The publication titled, Extracellular vesicles derived from cardiosphere-derived cells as a potential antishock therapeutic was published in the international peer-reviewed journal, The Journal of Trauma and Acute Care Surgery in collaboration with researchers at the United States Army Institute of Surgical Research (USAISR).
  • The military continues to look for therapeutics that can be delivered in the field to stabilize wounded warriors.
  • While cell therapy held promise in that arena, a lyophilized product that does not require ultra-cold storage is preferable.
  • The goal of the study was to determine the therapeutic potential of CDC-EVs in a rat model of acute traumatic coagulopathy induced by polytrauma and hemorrhagic shock.

'Since Your Life Story Would Make the Most Amazing Headline, What Would it Say?' - Two Special Brothers, a Reformed Ex-L.A. Gang Member and a Paralympic Purple-Heart Recipient, Continue to Remind Everyone That 'We Are All One Story'

Retrieved on: 
Monday, June 21, 2021
Medical specialties, Clinical medicine, Articles, Adverse childhood experiences, Mental health, Anxiety disorders, Anxiety, Emotions, Psychological trauma, Rattle, Major trauma

WAAOS is currently amassing an expanding library of uniquely heartfelt tales told by people from all walks of life.

Key Points: 
  • WAAOS is currently amassing an expanding library of uniquely heartfelt tales told by people from all walks of life.
  • "Well, for example, when you see my brother, when you see his scars from war, you physically know that he's been through some trauma.
  • Anxiety or depression or lost hopes and dreams: all that other life-stuff that rattles around in all our heads.
  • Having found that wisdom again, the brothers set out on a mission to help others remember the same truth: Each story is worth telling.